AIP and Alzheimer disease: Around the same time, Williams et al. identified an S. hominis cyclic AIP variant (AIP-I) that not only inhibited S. aureus Agr signaling when purified AIP-I was applied to the skin but also prevented disease when S. aureus was coadministered with S. hominis in a murine model of AD (7).